Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
NCT05394363 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150000
Last updated 2025-08-03
Summary
Generation Victoria (GenV) is a longitudinal, population-based study of Victorian children and their parents that will bring together data on a wide range of conditions ,exposures and outcomes. GenV blends study-collected, study-enhanced and linked data. It will be multi-purpose, supporting observational, interventional, health services and policy research within the same cohort. It is designed to address physical, mental and social issues experienced during childhood, as well as the antecedents of a wide range of diseases of ageing. It seeks to generate translatable evidence (prediction, prevention, treatments, services) to improve future wellbeing and reduce the future disease burden of children and adults.
The GenV Cohort 2020s is open to all children born over a two-year period, and their parents, residing in the state of Victoria Australia. The GenV Cohort 2020s is preceded by an Advance Cohort of children born between 5 Dec 2020 and 3 October 2021, and their parents. This comprises all families recruited at GenV's Vanguard hospital (Joan Kirner Women's and Children's) and at birthing hospitals throughout Victoria as GenV scaled up to commence recruiting for the GenV Cohort 2020s. The Advance Cohort have ongoing and full participation in GenV for their lifetime unless they withdraw but may have less complete data and biosamples.
Conditions
- Mental Health
- Child Wellbeing
- Infant Health
- Child Health
- Reproductive Health
- Healthy Aging
- Health Equity
- Quality of Life
- Social Determinants of Health
- Environmental Exposure
- Genetics
- Cognition
- Learning
- Child Development
- Congenital Abnormalities
- Disability
- Injuries
- Communicable Diseases
- Noncommunicable Diseases
- Physical Fitness
- Diet
- Obesity
- Allergy and Immunology
- Inflammation
- Intergenerational Relations
Sponsors & Collaborators
-
The Paul Ramsay Foundation
collaborator UNKNOWN -
Royal Children's Hospital
collaborator OTHER -
Victoria State Government
collaborator UNKNOWN -
Royal Children's Hospital Foundation
collaborator UNKNOWN - collaborator OTHER
-
National Health and Medical Research Council, Australia
collaborator OTHER -
Medical Research Future Fund
collaborator OTHER -
Angliss Health Service
collaborator UNKNOWN -
Bairnsdale Regional Health Service
collaborator UNKNOWN -
Grampians Health - Ballarat Base Hospital
collaborator UNKNOWN -
Bass Coast Regional Health
collaborator UNKNOWN -
The Bays Private Hospital
collaborator UNKNOWN -
Benalla & District Memorial Hospital
collaborator UNKNOWN -
Bendigo Hospital
collaborator UNKNOWN -
Box Hill Hospital
collaborator UNKNOWN -
Cabrini Private Hospital
collaborator UNKNOWN -
Casey Hospital
collaborator UNKNOWN -
Castlemaine Hospital
collaborator UNKNOWN -
Central Gippsland Health Service
collaborator UNKNOWN -
Colac Area Health
collaborator UNKNOWN -
Dandenong Hospital
collaborator UNKNOWN -
Bacchus Marsh - Western Health (formerly Djerriwarrh Health Service)
collaborator UNKNOWN -
East Grampians Health Service
collaborator UNKNOWN -
Echuca Regional Health
collaborator UNKNOWN -
Epworth Freemason's Private Hospital
collaborator UNKNOWN -
Frances Perry Private Hospital
collaborator UNKNOWN -
Peninsula Health
collaborator OTHER_GOV -
Epworth Geelong
collaborator UNKNOWN -
Geelong University Hospital
collaborator UNKNOWN -
Goulburn Valley Health
collaborator UNKNOWN -
Hamilton Base Hospital
collaborator UNKNOWN -
Jessie McPherson Private Hospital
collaborator UNKNOWN -
Joan Kirner Women's and Children's Hospital
collaborator UNKNOWN -
The Kilmore & District Hospital
collaborator UNKNOWN -
Latrobe Regional Hospital
collaborator UNKNOWN -
Leongatha Memorial Hospital
collaborator UNKNOWN -
Mansfield District Hospital
collaborator UNKNOWN -
Maryborough District Health Service
collaborator UNKNOWN -
Mercy Hospital for Women
collaborator UNKNOWN -
Mercy Werribee Public Hospital
collaborator UNKNOWN -
Mildura Base Hospital
collaborator UNKNOWN -
Mitcham Private Hospital
collaborator UNKNOWN -
Monash Medical Centre
collaborator OTHER -
Northeast Health Wangaratta
collaborator UNKNOWN -
The Northern Hospital
collaborator UNKNOWN -
Northpark Private Hospital
collaborator UNKNOWN -
Peninsula Private Hospital
collaborator UNKNOWN -
Royal Women's Hospital
collaborator UNKNOWN -
Sandringham & District Memorial Hospital
collaborator UNKNOWN -
South Gippsland Hospital
collaborator UNKNOWN -
South West Healthcare Camperdown
collaborator UNKNOWN -
South West Healthcare Warnambool
collaborator UNKNOWN -
St John of God Hospital Ballarat
collaborator UNKNOWN -
St John of God Hospital Bendigo
collaborator UNKNOWN -
St John of God Hospital Berwick
collaborator UNKNOWN -
St John of God Hospital Geelong
collaborator UNKNOWN -
St Vincents Private Hospital
collaborator UNKNOWN -
Swan Hill District Hospital
collaborator UNKNOWN -
Waverley Private Hospital
collaborator UNKNOWN -
West Gippsland Healthcare Group
collaborator UNKNOWN -
Grampians Health - Horsham (formerly Wimmera Health Care Group)
collaborator UNKNOWN -
Albury Wodonga Health
collaborator UNKNOWN -
Yarrawonga District Health Service
collaborator UNKNOWN -
Portland District Health
collaborator UNKNOWN -
Murdoch Childrens Research Institute
lead OTHER
Principal Investigators
-
Melissa Wake, MBChB, FRACP, FAHMS, MD · Murdoch Childrens Research Institute
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-04
- Primary Completion
- 2033-10-31
- Completion
- 2033-10-31
Countries
- Australia
Study Locations
More Related Trials
-
A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants
NCT01399853 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccination In Pregnancy Gene Signature: VIP Signature Study
NCT03284515 ·Status: COMPLETED
-
Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series
NCT05457946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults
NCT03208101 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
NCT00362336 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
NCT06618196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71
NCT03582761 ·Status: COMPLETED ·Phase: PHASE4
-
Optimising Protection for Pregnant Women and Infants With Maternal Vaccination
NCT03457194 ·Status: ACTIVE_NOT_RECRUITING
-
The Optimal Timing of Vaccination in Pregnancy
NCT06466629 ·Status: RECRUITING
-
DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants
NCT02094833 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines
NCT02643433 ·Status: COMPLETED ·Phase: PHASE4
-
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
NCT00932269 ·Status: UNKNOWN
-
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
NCT06947499 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines
NCT01651247 ·Status: COMPLETED
-
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
NCT06209398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children
NCT01267903 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
NCT01341639 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety
NCT00263692 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
NCT01349829 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of SCB-1019T in Children
NCT06666179 ·Status: WITHDRAWN ·Phase: PHASE1
-
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
NCT00197002 ·Status: COMPLETED ·Phase: PHASE3
-
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
NCT03614702 ·Status: COMPLETED ·Phase: PHASE3
-
METHORIVAC - Vaccinal Pharmacoepidemiologic
NCT01931813 ·Status: COMPLETED
-
Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
NCT05584202 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
NCT04941261 ·Status: UNKNOWN ·Phase: PHASE2